Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.1.30EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.1.30EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.1.30ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.30ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.11EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BE.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.11ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BE.11ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BE.11EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BE.11EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BE.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.62EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.62EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.62ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.2.62ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.2.62EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.2.62EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.2.62ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.62ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.24EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.24ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.2.24ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.2.24EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.2.24EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.2.24ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.24ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BA.5.8ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.8ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-4212.07Germany
BA.5.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-2902.6China
BA.5.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
BA.2.13.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.13.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.13.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.13.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.13.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.13.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.13.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.13.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.28EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BF.28ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.28ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-3196.01Germany
BF.28EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.28EHuang-EGCAGCAGTACGCACACAATC20552637626357R-3384China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used